Plain-English translation of NCT06716580 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new blood test that looks for specific genetic changes related to lung cancer. The test searches your blood for EGFR mutations, which are gene changes found in many people with lung cancer. Researchers want to see if this blood test can catch lung cancer early, before you have any symptoms, especially in Asian and Latino communities who are often underrepresented in cancer research.
Many people from Asian and Latino backgrounds develop lung cancer even though they've never smoked, but they're often excluded from standard lung cancer screening programs. This study exists to develop a better screening tool that works for these communities and can find cancer earlier, when treatment options are most effective.
You likely qualify if…
You likely don't qualify if…
You'll visit the clinic to complete a baseline questionnaire and have a blood sample drawn. Your blood will be tested using the new screening test, and if it comes back positive, the result will be confirmed with another test. If confirmed, you'll have a CT scan of your chest to look for any tumors; if nothing is found, you'll return for another scan in 12 months. You may also be invited to complete an optional survey or join a virtual focus group to share your thoughts about the screening experience.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States